Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 2
1990 1
1993 1
1995 2
1996 1
1997 5
1998 4
1999 1
2000 7
2002 2
2004 2
2005 5
2006 2
2007 1
2008 1
2013 4
2014 4
2015 7
2016 5
2017 5
2018 1
2019 6
2020 9
2021 6
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

73 results
Results by year
Filters applied: . Clear all
Page 1
High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy.
Seitz-Polski B, Dahan K, Debiec H, Rousseau A, Andreani M, Zaghrini C, Ticchioni M, Rosenthal A, Benzaken S, Bernard G, Lambeau G, Ronco P, Esnault VLM. Seitz-Polski B, et al. Among authors: benzaken s. Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1173-1182. doi: 10.2215/CJN.11791018. Epub 2019 Jul 24. Clin J Am Soc Nephrol. 2019. PMID: 31340979 Free PMC article. Clinical Trial.
Genetic aspects of exercise and rhabdomyolysis.
Yamin C, Meckel Y, Oliveira J, Duarte JA, Ben-Zaken S, Nemet D, Eliakim A. Yamin C, et al. Pediatr Endocrinol Rev. 2014 Jun;11(4):400-8. Pediatr Endocrinol Rev. 2014. PMID: 24988693 Review.
Rituximab bioavailability in primary membranous nephropathy.
Boyer-Suavet S, Andreani M, Cremoni M, Brglez V, Benzaken S, Bernard G, Nachman P, Esnault V, Seitz-Polski B. Boyer-Suavet S, et al. Among authors: benzaken s. Nephrol Dial Transplant. 2019 Aug 1;34(8):1423-1425. doi: 10.1093/ndt/gfz041. Nephrol Dial Transplant. 2019. PMID: 30929012 No abstract available.
Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy.
Teisseyre M, Cremoni M, Boyer-Suavet S, Crepin T, Benzaken S, Zorzi K, Esnault V, Brglez V, Seitz-Polski B. Teisseyre M, et al. Among authors: benzaken s. Front Immunol. 2021 Oct 13;12:738788. doi: 10.3389/fimmu.2021.738788. eCollection 2021. Front Immunol. 2021. PMID: 34721403 Free PMC article.
73 results